Treatment of Metastatic Breast Cancer: State-of-the-Art, Subtypes and Perspectives
Perspectives in the Treatment of Metastatic Breast Cancer
NS El Saghir, A Tfayli, HA Hatoum, Z Nachef, P Dinh, A Awada
Yes
20111101
2011 Dec 1
Crit Rev Oncol Hematol
Treatment of Metastatic Breast Cancer: State-of-the-Art, Subtypes and Perspectives
Crit Rev Oncol Hematol. 2011 Dec 1;80(3):433-449, NS El Saghir, A Tfayli, HA Hatoum, Z Nachef, P Dinh, A Awada
Abstract
Abstract
Current treatment of metastatic breast cancer (MBC) aims at achieving meaningful clinical responses, improved quality of life, long-term remissions, prolonged survival, and dares to hope for a cure in a small percentage of cases. This article will discuss both consensus and controversies in the management of MBC in the context of the new evolving breast cancer molecular classification. Hormonal therapy remains the mainstay of management of MBC Luminal A and B. Data is emerging on management of ErbB2-positive...
